Home > Financial Ratios > VALIANT LABORATORIES

VALIANT LABORATORIES
Core EBITDA Growth

    Back to All Ratios
VALIANT LABORATORIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for VALIANT LABORATORIES
Please provide your vote to see the results

VALIANT LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023
   Core EBITDA Growth(%) -40.72-96.81-

What is the latest Core EBITDA Growth ratio of VALIANT LABORATORIES ?

The latest Core EBITDA Growth ratio of VALIANT LABORATORIES is -40.72 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-40.72
Mar2024-96.81
Mar2023-

How is Core EBITDA Growth of VALIANT LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 -40.72
Negative
Mar2024 -96.81
0
Mar2023 0 -

Other Financial Ratios of VALIANT LABORATORIES


Compare Core EBITDA Growth ratio of peers of VALIANT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VALIANT LABORATORIES ₹411.6 Cr -3.8% 13.1% -19.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹453,750.0 Cr 0.6% 13.6% 8.4% Stock Analytics
DIVIS LABORATORIES ₹182,117.0 Cr 1.5% 9.1% 9.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹151,314.0 Cr 1.5% 8.2% 35.7% Stock Analytics
CIPLA ₹113,225.0 Cr -2.1% 13.7% -6.7% Stock Analytics
DR REDDYS LABORATORIES ₹110,037.0 Cr -1.4% 8% 7.4% Stock Analytics


VALIANT LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VALIANT LABORATORIES

-3.8%

13.1%

-19.9%

SENSEX

-0.3%

-4.3%

-8.9%


You may also like the below Video Courses